Compounded Semaglutide vs Sermorelin

An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.

How Do They Compare?

Compounded Semaglutide (GLP-1 receptor agonist for weight management) and Sermorelin (Growth hormone releasing peptide for vitality) are both options in weight-management and peptide space. Compounded Semaglutide Compounded semaglutide is a GLP-1 receptor agonist that may help regulate appetite and support weight management goals when combined with diet and exercise. Sermorelin Sermorelin is a growth hormone-releasing hormone analog that may stimulate the natural production of growth hormone to support vitality, body composition, and overall wellness. Your provider can help determine which treatment, if any, may be appropriate based on your individual health profile and goals.

All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.

Side-by-Side Comparison

Compounded Semaglutide

Available Now
$285/mo

If prescribed by a provider

Category

weight-management

Description

GLP-1 receptor agonist for weight management

Features

  • May help reduce appetite and food cravings
  • Supports sustainable weight management
  • Weekly subcutaneous injection
  • Dosage gradually increased under provider supervision

Considerations

  • Compounded medications are not FDA-approved
  • Common side effects may include nausea, vomiting, and diarrhea
  • Not suitable for individuals with a history of medullary thyroid carcinoma
  • Requires ongoing medical supervision

Sermorelin

Available Now
$285/mo

If prescribed by a provider

Category

peptide

Description

Growth hormone releasing peptide for vitality

Features

  • May support natural growth hormone production
  • May help improve body composition and energy
  • May support better sleep quality
  • Administered via subcutaneous injection

Considerations

  • Compounded medications are not FDA-approved for this use
  • Side effects may include injection site reactions and headache
  • Not appropriate for individuals with active malignancies
  • Requires regular monitoring

Frequently Asked Questions

Compounded tirzepatide is not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.

Ready to Explore Your Options?

Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.

Get Started

Ready to get started?

Talk to a licensed provider

Get Started